Sandbox Reserved 1470
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
{{Sandbox_Reserved_BHall_1}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | {{Sandbox_Reserved_BHall_1}}<!-- PLEASE ADD YOUR CONTENT BELOW HERE --> | ||
==Structure and Mechanism of Cysteine Peptidase Gingipain K (KGP), a Major Virulence Factor of ''Porphyromonas gingivitis'' in Periodontitis== | ==Structure and Mechanism of Cysteine Peptidase Gingipain K (KGP), a Major Virulence Factor of ''Porphyromonas gingivitis'' in Periodontitis== | ||
- | <StructureSection load='4rbm' size='340' side='right' caption='Structure of Cystein Peptidase Gingapain (KGP)' scene=''> | + | <StructureSection load='4rbm' size='340' side='right' caption='Structure of Cystein Peptidase Gingapain K (KGP)' scene=''> |
==Function== | ==Function== |
Current revision
This Sandbox is Reserved from October 22, 2018 through April 30, 2019 for use in the course Biochemistry taught by Bonnie Hall at the Grand View University, Des Moines, IA USA. This reservation includes Sandbox Reserved 1456 through Sandbox Reserved 1470. |
To get started:
More help: Help:Editing |
Structure and Mechanism of Cysteine Peptidase Gingipain K (KGP), a Major Virulence Factor of Porphyromonas gingivitis in Periodontitis
|
References
- ↑ de Diego I, Veillard F, Sztukowska M, Guevara T, Potempa B, Pomowski A, Huntington JA, Potempa J, Gomis-Ruth FX. Structure and mechanism of cysteine peptidase Kgp, a major virulence factor of Porphyromonas gingivalis in periodontitis. J Biol Chem. 2014 Sep 29. pii: jbc.M114.602052. PMID:25266723 doi:http://dx.doi.org/10.1074/jbc.M114.602052
- ↑ Yongqing T, Potempa J, Pike RN, Wijeyewickrema LC. The lysine-specific gingipain of Porphyromonas gingivalis : importance to pathogenicity and potential strategies for inhibition. Adv Exp Med Biol. 2011;712:15-29. doi: 10.1007/978-1-4419-8414-2_2. PMID:21660656 doi:http://dx.doi.org/10.1007/978-1-4419-8414-2_2
- ↑ Tilakaratne A, Soory M. Anti-inflammatory Actions of Adjunctive Tetracyclines and Other Agents in Periodontitis and Associated Comorbidities. Open Dent J. 2014 May 30;8:109-24. doi: 10.2174/1874210601408010109. eCollection , 2014. PMID:24976875 doi:http://dx.doi.org/10.2174/1874210601408010109
- ↑ Kurita-Ochiai T, Yamamoto M. Periodontal pathogens and atherosclerosis: implications of inflammation and oxidative modification of LDL. Biomed Res Int. 2014;2014:595981. doi: 10.1155/2014/595981. Epub 2014 May 18. PMID:24949459 doi:http://dx.doi.org/10.1155/2014/595981
- ↑ Maresz KJ, Hellvard A, Sroka A, Adamowicz K, Bielecka E, Koziel J, Gawron K, Mizgalska D, Marcinska KA, Benedyk M, Pyrc K, Quirke AM, Jonsson R, Alzabin S, Venables PJ, Nguyen KA, Mydel P, Potempa J. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD). PLoS Pathog. 2013 Sep;9(9):e1003627. doi: 10.1371/journal.ppat.1003627. Epub 2013, Sep 12. PMID:24068934 doi:http://dx.doi.org/10.1371/journal.ppat.1003627
- ↑ Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, Leonard P, Li J, Burgdorf K, Grarup N, Jorgensen T, Brandslund I, Nielsen HB, Juncker AS, Bertalan M, Levenez F, Pons N, Rasmussen S, Sunagawa S, Tap J, Tims S, Zoetendal EG, Brunak S, Clement K, Dore J, Kleerebezem M, Kristiansen K, Renault P, Sicheritz-Ponten T, de Vos WM, Zucker JD, Raes J, Hansen T, Bork P, Wang J, Ehrlich SD, Pedersen O. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013 Aug 29;500(7464):541-6. doi: 10.1038/nature12506. PMID:23985870 doi:http://dx.doi.org/10.1038/nature12506
- ↑ May M. Drug development: Time for teamwork. Nature. 2014 May 1;509(7498):S4-5. doi: 10.1038/509S4a. PMID:24784427 doi:http://dx.doi.org/10.1038/509S4a
- ↑ Hede K. Antibiotic resistance: An infectious arms race. Nature. 2014 May 1;509(7498):S2-3. doi: 10.1038/509S2a. PMID:24784426 doi:http://dx.doi.org/10.1038/509S2a